The COVID-19 pandemic has led to unprecedented challenges. In particular, the impact of COVID-19 on neurological services and patients has been immense, as highlighted in a recent Editorial.[@bib1] Despite the heightened burden felt by neurologists, the dedication of our authors and reviewers is not waning. Submissions to *The Lancet Neurology* between Jan 1 and June 14, 2020, increased by around 70% compared with the same period last year. Unabated expert advice from our clinical and statistical reviewers from around the world is ensuring the continued publication of the highest quality research and reviews for our readers.

The journal continues to strive towards the [goal](https://www.thelancet.com/about-us){#interrefs10} of the *Lancet* group of disseminating *the best science for better lives.* Our achievement is reflected by the continued placement of *The Lancet Neurology* as the leading clinical neurology journal, according to the 2019 Journal Citation Report. The names of everyone who reviewed papers for the journal throughout 2019 are listed in the [appendix](#sec1){ref-type="sec"}; those who reviewed five papers, or more, are marked with an asterisk. We extend our warmest gratitude to all these reviewers.
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